1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Opioid Abatement Advisory Commission Treatment Grants 2025 is sponsored by Kentucky Opioid Abatement Advisory Commission (OAAC). The Opioid Abatement Advisory Commission approved $19. 8 million in grant applications to help people recovering from substance use disorder and implement prevention programs.
The Treatment Grants portion totals over $12 million and funds programs providing licensed residential treatment, OUD prevention, access to OUD treatment and recovery resources, coordinated pre- and post-release reentry and recovery-based programming for justice-involved individuals, and integrated care for pregnant mothers with OUD and their families.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: 75 organizations across Kentucky, including the Hope Center, Goodwill Industries of Kentucky, Tri-County Community Action Agency, and Legal Aid of the Bluegrass, among others. Specific eligibility would depend on the individual program component awarded. Confirm the full requirements in the official notice before applying.
The current listing shows totaling $12,625,730 (individual awards vary, e.g., $93,745 - $397,539). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Opioid Abatement Advisory Commission Treatment Grants 2025 is funded by Kentucky Opioid Abatement Advisory Commission (OAAC). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Kentucky. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe FY2026 COPS Anti-Heroin Task Force program funds statewide opioid-interdiction task forces with awards up to $4 million and no local match. But eligibility is narrower than most agencies assume, and there are two deadlines — July 23 and July 29. Here's the deep dive on who qualifies and how to build a competitive application.
Read articleThe May 29, 2026 OMB proposed rewrite of 2 CFR 200 is being read primarily as a cost-principles document. The structural change that will reshape how federal grants get decided is proposed §200.205, which requires senior political appointees to conduct a pre-issuance review of all discretionary awards — and the companion provision that makes peer-review recommendations 'advisory only' and not binding on agency decision-makers. The combined effect is the subordination of merit review to political review across NSF, NIH, DOE, USDA, and every other agency that runs peer-reviewed grant competitions. Why this is structurally different from prior administrations' political influence, what the 45-day comment window means for affected institutions, and the strategy for applicants whose proposals will be reviewed under the new framework starting October 1, 2026.
Read article